TY - JOUR
T1 - Reversible cardiac disease features in an inducible CUG repeat RNA–expressing mouse model of myotonic dystrophy
AU - Rao, Ashish N.
AU - Campbell, Hannah M.
AU - Guan, Xiangnan
AU - Word, Tarah A.
AU - Wehrens, Xander H.T.
AU - Xia, Zheng
AU - Cooper, Thomas A.
N1 - Funding Information:
ECG and echocardiography studies were performed at the Mouse Metabolic and Phenotyping Core at Baylor College of Medicine (BCM) supported by funds from the NIH (UM1HG006348, R01DK114356). FISH-IF images were acquired in the Integrated Microscopy Core at BCM, funded by the NIH (DK56338, and CA125123), CPRIT (RP150578, RP170719), the Dan L. Duncan Comprehensive Cancer Center, and the John S. Dunn Gulf Coast Consortium for Chemical Genomics. RNA library preparation and next-generation sequencing was performed at the Genomic and RNA Profiling Core at BCM under the direction of core director Daniel Kraushaar, and funding support from NIH (NIDDK-DK56338, NCI-CA125123, and 1S10OD02346901). This project was funded by grants from the NIH (R01HL045565, R01AR045653, R01AR060733, and R01HL147020) and the Muscular Dystrophy Association (MDA276796 and MDA602529) to TAC and a Wyck-Myotonic Dystrophy Foundation predoctoral fellowship grant to ANR. XHTW was funded by grants from the NIH (R01HL089598, R01HL091947, R01HL117641, and R01HL147108), HMC was funded by NIH grant F30HL140782, and TAW was funded by NIH grant T32HL139430-01A1. ZX was funded by NIH/NLM grant K01LM012877 and the Medical Research Foundation of Oregon. We thank Yuriana Aguilar for assisting with preparation of the revised manuscript. We thank Donnie Bundman for her work on transgene development. We also thank members of the Cooper lab for their valuable discussions and help throughout the project. Images were created with BioRender.
Publisher Copyright:
Copyright: © 2021, Rao et al.
PY - 2021/3/8
Y1 - 2021/3/8
N2 - Myotonic dystrophy type 1 (DM1) is caused by a CTG repeat expansion in the DMPK gene. Expression of pathogenic expanded CUG repeat (CUGexp) RNA causes multisystemic disease by perturbing the functions of RNA-binding proteins, resulting in expression of fetal protein isoforms in adult tissues. Cardiac involvement affects 50% of individuals with DM1 and causes 25% of disease-related deaths. We developed a transgenic mouse model for tetracycline-inducible and heart-specific expression of human DMPK mRNA containing 960 CUG repeats. CUGexp RNA is expressed in atria and ventricles and induced mice exhibit electrophysiological and molecular features of DM1 disease, including cardiac conduction delays, supraventricular arrhythmias, nuclear RNA foci with Muscleblind protein colocalization, and alternative splicing defects. Importantly, these phenotypes were rescued upon loss of CUGexp RNA expression. Transcriptome analysis revealed gene expression and alternative splicing changes in ion transport genes that are associated with inherited cardiac conduction diseases, including a subset of genes involved in calcium handling. Consistent with RNA-Seq results, calcium-handling defects were identified in atrial cardiomyocytes isolated from mice expressing CUGexp RNA. These results identify potential tissue-specific mechanisms contributing to cardiac pathogenesis in DM1 and demonstrate the utility of reversible phenotypes in our model to facilitate development of targeted therapeutic approaches.
AB - Myotonic dystrophy type 1 (DM1) is caused by a CTG repeat expansion in the DMPK gene. Expression of pathogenic expanded CUG repeat (CUGexp) RNA causes multisystemic disease by perturbing the functions of RNA-binding proteins, resulting in expression of fetal protein isoforms in adult tissues. Cardiac involvement affects 50% of individuals with DM1 and causes 25% of disease-related deaths. We developed a transgenic mouse model for tetracycline-inducible and heart-specific expression of human DMPK mRNA containing 960 CUG repeats. CUGexp RNA is expressed in atria and ventricles and induced mice exhibit electrophysiological and molecular features of DM1 disease, including cardiac conduction delays, supraventricular arrhythmias, nuclear RNA foci with Muscleblind protein colocalization, and alternative splicing defects. Importantly, these phenotypes were rescued upon loss of CUGexp RNA expression. Transcriptome analysis revealed gene expression and alternative splicing changes in ion transport genes that are associated with inherited cardiac conduction diseases, including a subset of genes involved in calcium handling. Consistent with RNA-Seq results, calcium-handling defects were identified in atrial cardiomyocytes isolated from mice expressing CUGexp RNA. These results identify potential tissue-specific mechanisms contributing to cardiac pathogenesis in DM1 and demonstrate the utility of reversible phenotypes in our model to facilitate development of targeted therapeutic approaches.
UR - http://www.scopus.com/inward/record.url?scp=85102531643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102531643&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.143465
DO - 10.1172/jci.insight.143465
M3 - Article
C2 - 33497365
AN - SCOPUS:85102531643
SN - 2379-3708
VL - 6
JO - JCI insight
JF - JCI insight
IS - 5
M1 - e143465
ER -